She founded Histogen
in 2007, focused on developing therapies that work to stimulate the stem cells in the body to regenerate tissues and organs.
Through Histogen's technology process, which mimics the embryonic environment including conditions of low oxygen and suspension, cells are triggered to become multipotent, and naturally produce these proteins associated with skin renewal.
Histogen cell technology harnesses the power of growth factors and stem-cell signaling molecules for skin rejuvenation that complements Allergan's flagship growth factor technology - TNS, according to the company.
First created at Histogen as a three-product line for anti-aging and post-resurfacing, Regenica was licensed by Suneva Medical in 2012 and has grown to the current advanced rejuvenation system of six products sold through medical aesthetic professionals.
licensing rights to Histogen's multipotent CCM and the Re-Genica branded line of products for topical applications in the licensed market.
"The applications for this proprietary multipotent CCM within the field of medical aesthetics are numerous and, based upon the way the proteins within the complex signal the body's own stem cells to rejuvenate and regenerate skin, potentially groundbreaking," said Histogen CEO Gail K.
The takeover of Histogen will aid Stratus Mediaa[euro](tm)s expansion into the biotechnology industry, especially into the aesthetics and therapeutics fields, the company said in a press release.
Under the terms of the non-binding LoI, the acquisition will result into the creation of Restorgenex Corporation with headquarters in San Diego and Histogen as its wholly-owned subsidiary.
The takeover of Histogen will aid Stratus Media's expansion into the biotechnology industry, especially into the aesthetics and therapeutics fields, the company said in a press release.
The deal will be completed upon meeting customary closing conditions such as clearance by Histogen's shareholders.